DrugPatentWatch Database Preview
Litigation Details for ViiV Healthcare UK Ltd. v. Lupin Ltd. (D. Del. 2011)
» See Plans and Pricing
ViiV Healthcare UK Ltd. v. Lupin Ltd. (D. Del. 2011)
Docket | Start Trial | Date Filed | 2011-06-29 |
Court | District Court, D. Delaware | Date Terminated | 2014-01-23 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | Defendant | Referred To | |
Parties | LUPIN LTD. | ||
Patents | 6,417,191 | ||
Attorneys | Deanne M. Mazzochi | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in ViiV Healthcare UK Ltd. v. Lupin Ltd.
Details for ViiV Healthcare UK Ltd. v. Lupin Ltd. (D. Del. 2011)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2011-06-29 | 1 | Complaint | United States Patent No. 6,417,191 (“the ‘l9l patent”). This action is based upon the Patent Laws of the…§ l39l(b) and (c), and l400(b). THE PATENT 13. The ‘191 patent, entitled “Synergistic Combinations of…the ‘191 patent including the right to sue and to recover for any infringement of that patent, A true …during the term of the ‘191 patent, it would further infringe that patent under 35 U.S.C. § 271(a), (b…during the term of the ‘191 patent, it would further infringe the ‘191 patent under 35 U.S.C. § 271(a), | External link to document |
2012-11-15 | 126 | Opinion | Healthcare Co. assert U.S. Patent No. 6,417,191 ('" 191 Patent") against Defendants Lupin… Teva Pharmaceuticals, USA, Inc. 1 The '191 Patent relates to therapeutic combinations of anti-HIV… Construction Construction from Patent-in-Suit "(IS, 4R)- Plain and… Construction Construction Patent-in-Suit "combination" Plain… Construction Construction Patent-in-Suit "pharmaceutical Plain and | External link to document |
2013-07-12 | 210 | POST Trial Brief | Number (if applicable) ‘191 patent U.S. Patent No. 6,417,191 …purposes of patent infringement requires an element-by-element comparison of the patent claim and the…Product infringes any Asserted Claim of the ‘191 patent (4, 26, 27, 29, 30, 34, 36, 38, 39, and 47). …manufacture, use, or sale of the drug would infringe the patent “is properly grounded in the ANDA application and…. ViiV must show that “every limitation of the patent claim asserted” is satisfied “either literally | External link to document |
2013-07-16 | 216 | Redacted Document | collectively “Lupin”) infringement of U.S. Patent No. 6,417,191 (the “’191 patent”). Plaintiffs ViiV Healthcare…infringement case, ViiV presented the ’191 patent, portions of the ’191 patent’s prosecution history, the aforementioned…for a drug claimed in a patent or the use of which is claimed in a patent” if the ANDA applicant seeks…........ 13, 14 In re Alfuzosin Hydrochloride Patent Litig., No. 08-MD-1941, 2010 WL 1956286 …......... 5, 6, 13 In re Rosuvastatin Calcium Patent Litig., 719 F. Supp. 2d 388 (D. Del. 2010), | External link to document |
2013-12-16 | 257 | Opinion | ViiV") assert U.S. Patent No. 6,417,191 (''the' 191 Patent") against Defendants… '191 Patent is invalid as obvious. Lupin individually asserts that the '191 Patent is invalid…ofblocking patents. 38 Defendants main argument is that the existence of"blocking patents," owned… some appeal if the patent claims did not limit the term animal, here the patent claims explicitly limit…that the '161 Patent is not sufficiently enabled for a POSA to utilize the patent without undue experimentation | External link to document |
2014-01-27 | 276 | Patent/Trademark Report to Commissioner | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,417,191. (Attachments: # 1 …2011 24 January 2014 1:11-cv-00576 830 Patent Defendant District Court, D. Delaware | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |